Identification of Novel Interactions Between Domains of Myosin Binding Protein-C That Are Modulated by Hypertrophic Cardiomyopathy Missense Mutations

Abstract— Cardiac myosin binding protein-C (cMyBPC) is a modular protein consisting of 11 domains whose precise function and sarcomeric arrangement are incompletely understood. Identification of hypertrophic cardiomyopathy (HCM)–causing missense mutations in cMyBPC has highlighted the significance of certain domains. Of particular interest is domain C5, an immunoglobulin-like domain with a cardiac-specific insert, which is of unknown function yet is the site of two HCM-causing missense mutations. To identify interactors with this region, a human cardiac cDNA library was screened in a yeast two-hybrid (Y2H) assay using the C5 sequence as bait. Screening >7×106 clones surprisingly revealed that domain C5 preferentially bound to clones encoding C-terminal fragments of cMyBPC; the interacting region was narrowed to domain C8 by deletion mapping. A surface plasmon resonance assay using purified recombinant cMyBPC domains was used to measure the affinity of C5 and C8 in vitro (Ka=1×105 mol/L−1). This affinity was decreased about 2-fold by the HCM mutation R654H, and by at least 10-fold by the mutation N755K. Further Y2H assays also demonstrated specific binding between domains C7 and C10 of cMyBPC. Based on these novel interactions, and previous biochemical and structural data, we propose that cMyBPC molecules trimerize into a collar around the thick filament, with overlaps of domains C5-C7 of one cMyBPC with C8-C10 of another. We speculate that this interaction may be dynamically formed and released, thereby restricting or favoring cross-bridge formation, respectively. We suggest that the HCM mutations act by altering the cMyBPC collar, indicating its importance in thick filament structure and regulation.

[1]  F. E. Weber,et al.  The major myosin-binding domain of skeletal muscle MyBP-C (C protein) resides in the COOH-terminal, immunoglobulin C2 motif , 1993, The Journal of cell biology.

[2]  J. Squire,et al.  Myosin rod-packing schemes in vertebrate muscle thick filaments. , 1998, Journal of structural biology.

[3]  H Niimura,et al.  Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. , 1998, The New England journal of medicine.

[4]  T. Hewett,et al.  In vivo modeling of myosin binding protein C familial hypertrophic cardiomyopathy. , 1999, Circulation research.

[5]  H. Watkins,et al.  Altered Regulatory Properties of Human Cardiac Troponin I Mutants That Cause Hypertrophic Cardiomyopathy* , 2000, The Journal of Biological Chemistry.

[6]  M. Gautel,et al.  The C-protein (myosin binding protein C) family: regulators of contraction and sarcomere formation? , 1999, Reviews of physiology, biochemistry and pharmacology.

[7]  J. Seidman,et al.  Mutations in the cardiac myosin binding protein–C gene on chromosome 11 cause familial hypertrophic cardiomyopathy , 1995, Nature Genetics.

[8]  M. Gautel,et al.  Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C. , 1999, Journal of molecular biology.

[9]  R. Jeremy,et al.  Counselling issues in familial hypertrophic cardiomyopathy. , 1998, Journal of medical genetics.

[10]  V. Berezin,et al.  The First Immunoglobulin-like Neural Cell Adhesion Molecule (NCAM) Domain Is Involved in Double-reciprocal Interaction with the Second Immunoglobulin-like NCAM Domain and in Heparin Binding* , 1997, The Journal of Biological Chemistry.

[11]  M. Gautel,et al.  Phosphorylation switches specific for the cardiac isoform of myosin binding protein‐C: a modulator of cardiac contraction? , 1995, The EMBO journal.

[12]  S. Winegrad,et al.  Relation between crossbridge structure and actomyosin ATPase activity in rat heart. , 1998, Circulation research.

[13]  H. Watkins,et al.  Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. , 1999, Cardiovascular Research.

[14]  F. E. Weber,et al.  Complete sequence of human fast-type and slow-type muscle myosin-binding-protein C (MyBP-C). Differential expression, conserved domain structure and chromosome assignment. , 1993, European journal of biochemistry.

[15]  R. Starr,et al.  The interaction of C-protein with heavy meromyosin and subfragment-2. , 1978, The Biochemical journal.

[16]  B. Hainque,et al.  COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes. , 1999, Journal of molecular biology.

[17]  J. Moolman-Smook,et al.  The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: a unique profile of both independent and founder events. , 1999, American journal of human genetics.

[18]  I Kulikovskaya,et al.  Multiple structures of thick filaments in resting cardiac muscle and their influence on cross-bridge interactions. , 2001, Biophysical journal.

[19]  D. Vučković,et al.  Familial Hypertrophic Cardiomyopathy , 2007, Herz Kardiovaskuläre Erkrankungen.

[20]  H. C. Hartzell,et al.  Structure of C protein purified from cardiac muscle , 1985, The Journal of cell biology.

[21]  J. Beckmann,et al.  Cardiac myosin binding protein–C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy , 1995, Nature Genetics.

[22]  M. Davies,et al.  Hypercontractile Properties of Cardiac Muscle Fibers in a Knock-in Mouse Model of Cardiac Myosin-binding Protein-C* , 2001, The Journal of Biological Chemistry.

[23]  J. Cohen,et al.  Identification of the A-band localization domain of myosin binding proteins C and H (MyBP-C, MyBP-H) in skeletal muscle. , 1999, Journal of cell science.

[24]  M. Way,et al.  Expression of human plasma gelsolin in Escherichia coli and dissection of actin binding sites by segmental deletion mutagenesis , 1989, The Journal of cell biology.

[25]  M. Gautel,et al.  A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. , 1996, European journal of biochemistry.

[26]  R. Starr,et al.  A new protein of the thick filaments of vertebrate skeletal myofibrils. Extractions, purification and characterization. , 1973, Journal of molecular biology.

[27]  R. Starr,et al.  The structure of C-protein and X-protein molecules and a polymer of X-protein. , 1985, Journal of molecular biology.

[28]  A. Pastore,et al.  Tertiary structure of an immunoglobulin-like domain from the giant muscle protein titin: a new member of the I set. , 1995, Structure.

[29]  G. Offer C-Protein and the Periodicity in the Thick Filaments of Vertebrate Skeletal Muscle , 1973 .

[30]  J. Moolman-Smook,et al.  Identification of a new missense mutation in MyBP-C associated with hypertrophic cardiomyopathy. , 1998, Journal of medical genetics.

[31]  R. Starr,et al.  Interaction of C-protein with myosin, myosin rod and light meromyosin. , 1975, Journal of molecular biology.

[32]  S. Winegrad Cardiac myosin binding protein C. , 1999, Circulation research.

[33]  J. Seidman,et al.  Sarcomere Protein Gene Mutations in Hypertrophic Cardiomyopathy of the Elderly , 2002, Circulation.

[34]  R. Jeremy,et al.  Molecular pathology of familial hypertrophic cardiomyopathy caused by mutations in the cardiac myosin binding protein C gene. , 1998, Journal of medical genetics.

[35]  H. C. Hartzell,et al.  Effects of cholinergic and adrenergic agonists on phosphorylation of a 165,000-dalton myofibrillar protein in intact cardiac muscle. , 1982, The Journal of biological chemistry.

[36]  J. Trinick,et al.  Titin and the sarcomere symmetry paradox. , 2001, Journal of molecular biology.

[37]  Christine E. Seidman,et al.  α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere , 1994, Cell.

[38]  J. Tardiff,et al.  Cardiac troponin T mutations: correlation between the type of mutation and the nature of myofilament dysfunction in transgenic mice , 2001, The Journal of physiology.

[39]  M. Gautel,et al.  Letter to the Editor: Sequence specific resonance assignment of the central domain of cardiac Myosin Binding Protein C (MyBP-C) , 2002, Journal of biomolecular NMR.

[40]  M. Gautel,et al.  cAPK‐phosphorylation controls the interaction of the regulatory domain of cardiac myosin binding protein C with myosin‐S2 in an on‐off fashion , 1999, FEBS letters.